Risk/Benefit Tradeoff of Prolonging Dual Antiplatelet Therapy More Than 12 Months in TWILIGHT-Like High-Risk Patients After Complex Percutaneous Coronary Intervention
| Autor: | Wang, Hao-Yu, Dou, Ke-Fei, Yin, Dong, Xu, Bo, Zhang, Dong, Gao, Run-Lin |
|---|---|
| Zdroj: | In The American Journal of Cardiology 15 October 2020 133:61-70 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect